Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Infect Control Hosp Epidemiol ; 44(6): 885-890, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36263455

RESUMEN

OBJECTIVE: To determine risk factors for mechanical (noninfectious) complications in peripherally inserted central catheters (PICCs) in children. DESIGN: Retrospective cohort study. SETTING: Pediatric tertiary-care center in Nova Scotia, Canada. PATIENTS: Pediatric patients with a first PICC insertion. METHODS: All PICCs inserted between January 2001 until 2016 were included. Age-stratified (neonates vs non-neonates) Fine-Grey competing risk proportional hazard models were used to model the association between each putative risk factor and the time to mechanical complication or removal of the PICC for reasons not related to a mechanical complication. Models were adjusted for confounding variables identified through directed acyclic graphs. RESULTS: Of 3,205 patients with PICCs, 706 had mechanical complications (22% or 14 events/1000 device days). For both neonates and older children, disease group, lumen count, and prior leak were all associated with mechanical complications in the adjusted proportional hazards model. Access vein and prior infection were also associated with mechanical complications for neonates, and age group was associated with mechanical complications among non-neonates. CONCLUSIONS: We have identified several risk factors for mechanical complications in patients with PICCs that will help improve best practices for PICC insertion and care.


Asunto(s)
Infecciones Relacionadas con Catéteres , Cateterismo Venoso Central , Cateterismo Periférico , Catéteres Venosos Centrales , Humanos , Niño , Adolescente , Estudios Retrospectivos , Infecciones Relacionadas con Catéteres/epidemiología , Infecciones Relacionadas con Catéteres/etiología , Cateterismo Venoso Central/efectos adversos , Factores de Riesgo , Cateterismo Periférico/efectos adversos , Catéteres/efectos adversos , Nueva Escocia/epidemiología , Catéteres Venosos Centrales/efectos adversos , Catéteres de Permanencia/efectos adversos
2.
Curr Opin Support Palliat Care ; 16(4): 230-233, 2022 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-36349382

RESUMEN

PURPOSE OF REVIEW: The purpose of this review is to highlight the demand for fertility preservation among cancer survivors and to draw attention to areas where healthcare workers need to improve. As technology advances, maximizing cryopreservation rates will be paramount to increase the ability individuals to conceive after cancer treatment. RECENT FINDINGS: Guidelines recommending discussion of fertility for those diagnosed with cancer have been shown to increase patient satisfaction and overall quality of life. Our review demonstrated that increasing counseling rates remains an ongoing challenge and should remain an area of improvement for all healthcare professionals working in the oncology field. Formal programs to improve patient and provider education and access to fertility preservation increase uptake of fertility preservation. For men, many options exist to cryopreserve sperm; a slight delay to achieve fertility preservation has not been shown to lead to worse outcomes. Cryopreservation strategies differ based on puberty status and remain an active area of clinical research. SUMMARY: Improving fertility outcomes for cancer survivors is possible with appropriate counseling techniques at the time of cancer diagnosis. Clinicians should challenge current barriers for patient access to fertility preservation surrounding cancer treatments.


Asunto(s)
Preservación de la Fertilidad , Neoplasias , Masculino , Humanos , Calidad de Vida , Semen , Criopreservación , Oncología Médica , Neoplasias/complicaciones , Neoplasias/terapia
3.
Curr Oncol ; 29(3): 1808-1812, 2022 03 08.
Artículo en Inglés | MEDLINE | ID: mdl-35323348

RESUMEN

A standard curative intent approach of chemotherapy treatment for metastatic testicular cancer has been well established. However, there is little guidance for patients undergoing hemodialysis (HD) who require chemotherapy for this disease. Thus, we describe our treatment approach and rationale for a patient on HD with poor risk metastatic nonseminomatous germ cell tumor involving the testicle, lymph nodes, liver, and bone. After orchiectomy, five cycles of cisplatin and modified dose etoposide were delivered and strategically timed with HD. Treatment was complicated by significant neuropathy. Surgical resection of two liver lesions was performed after chemotherapy. Ten years post-chemotherapy, he remains free of clinical, biochemical, or radiological recurrence. While our patient remains free of disease after this treatment, the optimal chemotherapy and dialysis dose and schedule to maximize cure and minimize toxicity remains unknown.


Asunto(s)
Neoplasias de Células Germinales y Embrionarias , Neoplasias Primarias Secundarias , Neoplasias Testiculares , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Etopósido/uso terapéutico , Humanos , Masculino , Neoplasias de Células Germinales y Embrionarias/tratamiento farmacológico , Diálisis Renal , Neoplasias Testiculares/tratamiento farmacológico , Neoplasias Testiculares/patología
4.
Infect Control Hosp Epidemiol ; 43(11): 1634-1640, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-34930512

RESUMEN

BACKGROUND: Despite the numerous advantages of central venous catheters (CVCs), they have been associated with a variety of complications. Surveillance for mechanical complications of CVCs is not routine, so the true incidence and impact of this adverse patient outcome remains unclear. SETTING AND METHODS: Prospectively collected CVC data on mechanical complications were reviewed from a centralized database for all in-hospital patient days at our tertiary-care hospital from January 2001 to June 2016 in patients aged <19 years. Patient demographics, CVC characteristics, and rates of mechanical complications per 1,000 days of catheter use were described. RESULTS: In total, 8,747 CVCs were placed in 5,743 patients during the study period, which captured 780,448 catheter days. The overall mechanical complication rate was 6.1 per 1,000 catheter days (95% confidence interval [CI], 5.9-6.3). The highest complication rates were in nontunneled lines; this was consistent throughout the 15-year study period. Also, 521 CVCs (∼6%) were removed due to mechanical complications before therapy termination. Catheters with tip location in the superior vena cava or right atrium had the fewest complications. CONCLUSIONS: Mechanical complications of CVCs are a common and significant event in the pediatric population. We propose that CVC-associated mechanical complications become a routinely reported patient safety outcome.


Asunto(s)
Cateterismo Venoso Central , Catéteres Venosos Centrales , Humanos , Niño , Catéteres Venosos Centrales/efectos adversos , Cateterismo Venoso Central/efectos adversos , Estudios de Cohortes , Vena Cava Superior , Incidencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA